PharmaTimes https://pharmatimes.com in-depth news, features and insights for the pharmaceutical and healthcare sectors Thu, 12 Mar 2026 13:27:05 +0000 en-US hourly 1 https://pharmatimes.com/wp-content/uploads/2023/11/PT-icon-150x150.png PharmaTimes https://pharmatimes.com 32 32 232894315 MHRA approves new treatment for severe alopecia areata https://pharmatimes.com/news/mhra-approves-new-treatment-for-severe-alopecia-areata/ Thu, 12 Mar 2026 13:26:33 +0000 https://pharmatimes.com/?p=104332 Regulator authorises deuruxolitinib for adults with extensive hair loss

]]> 104332 Aplagon doses first patient in phase 2a trial of APAC https://pharmatimes.com/news/aplagon-doses-first-patient-in-phase-2a-trial-of-apac/ Thu, 12 Mar 2026 13:21:18 +0000 https://pharmatimes.com/?p=104330 Study aims to advance treatment options for severe peripheral arterial disease

]]> 104330 NHS to offer fezolinetant for menopause‑related hot flushes and night‑sweats https://pharmatimes.com/news/nhs-to-offer-fezolinetant-for-menopause-related-hot-flushes-and-night-sweats/ Wed, 11 Mar 2026 10:39:50 +0000 https://pharmatimes.com/?p=104326 NICE recommends non‑hormonal therapy for moderate to severe vasomotor symptoms

]]> 104326 UCB reports superiority of bimekizumab in psoriatic arthritis study https://pharmatimes.com/news/ucb-reports-superiority-of-bimekizumab-in-psoriatic-arthritis-study/ Wed, 11 Mar 2026 09:23:12 +0000 https://pharmatimes.com/?p=104324 BE BOLD trial shows bimekizumab outperforms risankizumab at Week 16

]]> 104324 Kainova reports positive results for DT‑9081 in advanced solid tumours https://pharmatimes.com/news/kainova-therapeutics-reports-positive-phase-1-results-for-dt-9081-in-advanced-solid-tumours/ Tue, 10 Mar 2026 09:28:21 +0000 https://pharmatimes.com/?p=104318 Early data show favourable safety and sustained target engagement for oral EP4 receptor antagonist

]]> 104318 EnteroBiotix completes enrolment for trial of EBX‑102‑02 https://pharmatimes.com/news/enterobiotix-completes-enrolment-for-phase-2a-trial-of-ebx-102-02-in-stem-cell-transplant-patients/ Tue, 10 Mar 2026 09:24:38 +0000 https://pharmatimes.com/?p=104316 Study will assess whether microbiome therapy can protect gut diversity during transplantation

]]> 104316 Lundbeck completes patient randomisation early in global MSA trial https://pharmatimes.com/news/lundbeck-completes-patient-randomisation-early-in-global-msa-trial/ Mon, 09 Mar 2026 10:36:43 +0000 https://pharmatimes.com/?p=104314 Phase 3 Mascot study reaches key milestone for potential first-in-class therapy

]]> 104314 Incyte treatment for advanced anal cancer approved in Europe https://pharmatimes.com/news/incyte-treatment-for-advanced-anal-cancer-approved-in-europe/ Mon, 09 Mar 2026 10:29:40 +0000 https://pharmatimes.com/?p=104312 EC decision introduces first systemic option for adults with advanced SCAC

]]> 104312 Dr Michelle Morrow https://pharmatimes.com/appointments/dr-michelle-morrow/ Thu, 05 Mar 2026 13:09:13 +0000 https://pharmatimes.com/?p=104299 Nucleome has appointed Dr Michelle Morrow as CSO

]]> 104299 Dr Klaas Zuideveld https://pharmatimes.com/appointments/dr-klaas-zuideveld/ Thu, 05 Mar 2026 12:41:11 +0000 https://pharmatimes.com/?p=104296 TECregen has appointed Dr Klaas Zuideveld as CEO

]]> 104296